Search for: "Warner Chilcott Pharmaceuticals Inc." Results 1 - 20 of 29
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2021, 2:54 pm by greggshapiro.admin
Prior authorization requirements are a common hurdle to increased drug sales and, as the earlier cases against Warner-Chilcott and Insys show, pharmaceutical companies have an incentive to overcome those requirements, sometimes by fraud. [read post]
9 Jul 2020, 10:56 am by Seeger Weiss LLP
Warner Chilcott plc, et al., in which $125 million was recovered in connection with a sprawling healthcare scheme. [read post]
9 Jul 2020, 10:56 am by Seeger Weiss LLP
Warner Chilcott plc, et al., in which $125 million was recovered in connection with a sprawling healthcare scheme. [read post]
31 Dec 2015, 8:16 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. et al. 1:15-cv-00761; filed August 31, 2015 in the District Court of Delaware • Plaintiffs: Warner Chilcott (US), LLC; Warner Chilcott Co., LLC; Qualicaps Co., Ltd. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
8 Sep 2011, 11:04 am by Tom Lamb
According to the FDA's Announcement for this September 2011 meeting, these two advisory committees will consider the benefits and risks of long-term use of osteoporosis medications in the bisphosphonate class of drugs, which were identified by the FDA as: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets, Merck & Co., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release… [read post]
7 Sep 2011, 4:22 am by Marie Louise
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) –… [read post]
29 Aug 2011, 7:56 am by Sonya Hubbard
Prior to that, he spent 17 years with Warner-Lambert, which is now part of Pfizer, Inc. [read post]
25 Jul 2011, 10:48 am by admin
., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and ACTONEL WITH CALCIUM (Copackaged) (risedronate sodium with calcium carbonate) tablets, Warner Chilcott, LLC; BONIVA (ibandronate sodium) tablets and injection, Roche Therapeutics, Inc.; RECLAST (zoledronic acid) injection, Novartis Pharmaceuticals Corp.; and the generic equivalents for these products, if any. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
22 Dec 2010, 3:01 am by Kelly
John’s patent research suit: St John’s University v Sanford M Bolton et al (Patent Docs) US: Affymetrix granted summary judgment for noninfingement of Illumina gene sequencing patents (Patent Docs)   Products Actonel (Risedronate sodium) – US: Patent infringement complaint filed following a Paragraph IV certification: Warner Chilcott Co. [read post]